About 6 results found for searched term "Actinomycin D" (0.151 seconds)
| Cat.No. | Name | Target |
|---|---|---|
| M4849 | 7-Aminoactinomycin D | Nucleic Acid Staining |
| 7-AAD | ||
| 7-aminoactinomycin D (7-aad) can bind to DNA, and the maximum excitation/emission wavelength is 546nm/647 nm. The best excitation laser is 561nm or 488nm. It gives red fluorescence and is often used to observe the nucleus and nucleic acid. Store in freezer (-5 to -30°C) away from light. The solvent was DMSO. *The compound is unstable in solutions, freshly prepared is recommended | ||
| M4881 | Actinomycin D | DNA/RNA Synthesis |
| Actinomycin Aiv; Dactinomycin; Act D; RASP-101 | ||
| Actinomycin d is a bright red rhomboid prisms or red powder. | ||
| M8641 | LP117 | Others |
| LP117 is a pirinixic acid derivative that interferes with ATP-binding cassette (ABC) transporter ABCB1-mediated substrates transport, including vincristine, vinorelbine, paclitaxel, and actinomycin D, but not doxorubicin, rhodamine 123, or JC-1. | ||
| M11495 | Recombinant Human TNF-α (E. coli) | Recombinant Proteins |
| TNF-alpha; Tumor necrosis factor ligand superfamily member 2; TNF-a; Cachectin | ||
| Recombinant human TNF-α protein (E. coli) is a homotrimer with a subunit molecular mass of 17.3 kDa. TNF-a plays a major role in growth regulation, differentiation, inflammation, viral replication, tumorigenesis, and autoimmune diseases; and in viral, bacterial, fungal, and parasitic infections. ED50 < 30.0 pg/ml, measured in a cytotoxicity assay using L-929 mouse fibrosarcoma cells in the presence of the metabolic inhibitor actinomycin D, corresponding to a specific activity of > 3.3 × 107 units/mg. | ||
| M21057 | Recombinant Human TNF-β (E. coli) | Recombinant Proteins |
| LTA; LT; TNFB; TNFSF1 | ||
| ED50 < 4.0 pg/ml, measured in a cytotoxicity assay using L-929 mouse fibrosarcoma cells in the presence of the metabolic inhibitor actinomycin D, corresponding to a specific activity of > 2.5 × 108 units/mg. | ||
| M53848 | Actinomycin X2 | Antibiotic |
| Actinomycin X2 (Actinomycin V), produced by many Streptomyces sp., shows strong inhibition of MRSA with a minimum inhibitory concentration (MIC) value of 0.25 μg/mL. | ||
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2023 AbMole BioScience. All Rights Reserved.
